REPREGEN
A spin-out from Imperial Innovations plc and headquartered within the Imperial College Incubator, RepRegen is poised to commercialize the initial product of its hard tissue repair and regeneration platform: StronBoneâ„¢ Bone Graft Substitute. The Company's hard tissue platform is based on 'smart' bioceramics designed to be used, initially, by orthopedic product manufacturers and surgeons. A major RepRegen materials science innovation is the use of Strontium, boosting the performance of the bioceramics.
REPREGEN
Social Links:
Industry:
Biopharma Biotechnology Health Care Manufacturing
Founded:
2006-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.repregen.com
Total Employee:
1+
Status:
Active
Contact:
44 20 7594 1326
Email Addresses:
[email protected]
Total Funding:
1.6 M USD
Technology used in webpage:
Nginx Baidu Analytics
Current Employees Featured
Founder
Investors List
Imperial Innovations
Imperial Innovations investment in Venture Round - RepRegen
Longbow Capital
Longbow Capital investment in Venture Round - RepRegen
Official Site Inspections
http://www.repregen.com
- Host name: ec2-13-223-25-84.compute-1.amazonaws.com
- IP address: 13.223.25.84
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "RepRegen"
RepRegen - Crunchbase Company Profile & Funding
RepRegen develops a hard tissue repair and regeneration platform to be used by orthopedic product manufacturers and surgeons.See details»
RepRegen (formally known as Bioceramic Therapeutics Ltd)
Website: http://www.repregen.com/ RepRegen is an emerging medical device company using patent-pending repair and regeneration technology in two platforms designed to mend and …See details»
RepRegen Ltd - Company Profile and News - Bloomberg Markets
RepRegen Limited operates as a medical device company. The Company uses proprietary repair and regeneration technology in two platforms designed to mend and regrow tissues in the body....See details»
RepRegen - Company Profile & Staff Directory - ContactOut
A spin-out from Imperial Innovations plc and headquartered within the Imperial College Incubator, RepRegen is poised to commercialize the initial product of its hard tissue repair and …See details»
RepRegenâ„¢ Ltd. (Formerly Known as BioCeramic Therapeutics
Jul 6, 2010 · RepRegenâ„¢ Ltd. is a medical device company that uses patent-pending repair and regeneration technology platforms designed to mend and regrow hard tissue such as bone …See details»
RepRegen - Funding, Financials, Valuation & Investors - Crunchbase
RepRegen develops a hard tissue repair and regeneration platform to be used by orthopedic product manufacturers and surgeons.See details»
RepRegen - Products, Competitors, Financials, Employees, …
RepRegen is an emerging medical device company using patent-pending repair and regeneration technology in two platforms designed to mend and regrow tissue in vivo. Use the CB Insights …See details»
RGEN Stock Quote Price and Forecast | CNN
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates...See details»
RepRegen Ltd. - BioCentury Company Profiles - BCIQ
Jun 27, 2011 · Historical deals and financings can be found by searching the organization's name in the BCIQ Deals and Financing Modules.See details»
RepRegen - Crunchbase
RepRegen develops a hard tissue repair and regeneration platform to be used by orthopedic product manufacturers and surgeons.See details»
RepRegenâ„¢ Ltd. (Formerly Known as BioCeramic Therapeutics
Nov 16, 2010 · LONDON-- (BUSINESS WIRE)--RepRegenTM Ltd the ‘smart biomaterials’ company, announced today that it has raised £1.03 million ($1.6 million). The financing was …See details»
Repligen Corporation (RGEN) - Yahoo Finance
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of …See details»
RepRegenâ„¢ Ltd. (Formerly Known as BioCeramic Therapeutics
Oct 20, 2010 · LONDON--(BUSINESS WIRE)--RepRegenâ„¢, the ‘smart biomaterials’ company, announced today that its Chief Science Officer, Molly Stevens, Ph.D., has been named one of …See details»
RepRegen Reports Potential Advance In The Repair And …
RepRegen, the 'smart biomaterials' company previously known as BioCeramic Therapeutics, announced recently that data from an in vitro study has demonstrated that its patented …See details»
RepRegen - Contacts, Employees, Board Members, Advisors
RepRegen has 1 current employee profile, CEOIan Brown. RepRegen develops a hard tissue repair and regeneration platform to be used by orthopedic product manufacturers and surgeons.See details»
RepRegen StronBone Receives CE Mark Approval - NS Medical …
Jul 6, 2010 · RepRegen is a medical device company that uses patent-pending repair and regeneration technology platforms designed to mend and regrow hard tissue such as bone …See details»
RepRegen Presents StronBone Bone Graft Substitute In Vivo Study …
Jun 1, 2010 · RepRegen said that the three-month data demonstrated that the bone in the defect was significantly stiffer 68% in the StronBone defect than in the control defect and the bone in …See details»
RepRegen releases six-month in-vivo data on StronBone bone …
Sep 30, 2010 · RepRegen CEO Ian Brown said that their platform is designed to dramatically upgrade the repair and regeneration of hard tissue such as bone and they intend to begin …See details»
RepRegen - Tech Stack, Apps, Patents & Trademarks - Crunchbase
RepRegen develops a hard tissue repair and regeneration platform to be used by orthopedic product manufacturers and surgeons.See details»
Repligen Corp. (RGEN) Stock Price Today - WSJ
View the latest Repligen Corp. (RGEN) stock price, news, historical charts, analyst ratings and financial information from WSJ.See details»